Eurobio Scientific Société Anonyme, headquartered in France, is a prominent player in the life sciences and diagnostics industry. Founded in 2000, the company has established itself as a leader in the development and distribution of innovative diagnostic solutions, particularly in the fields of infectious diseases, immunology, and molecular biology. With a strong presence across Europe and expanding operations in international markets, Eurobio Scientific offers a diverse range of products, including reagents, kits, and laboratory equipment. Their commitment to quality and innovation sets them apart, as they continually strive to enhance diagnostic accuracy and efficiency. Recognised for their expertise and reliability, Eurobio Scientific has achieved significant milestones, solidifying its market position as a trusted partner for healthcare professionals and laboratories worldwide.
How does Eurobio Scientific Société anonyme's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Eurobio Scientific Société anonyme's score of 28 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Eurobio Scientific Société anonyme, headquartered in France, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Eurobio Scientific's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. The company has not established any significant reduction initiatives or targets, which may reflect a broader context within the industry regarding climate action and sustainability efforts. In summary, without available emissions data or defined climate commitments, Eurobio Scientific's position on carbon emissions and climate action remains unspecified.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eurobio Scientific Société anonyme has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
